1
Most of the drugs used to treat vitreo-retinal diseases have a narrow concentration range over which they are effective. They may be toxic at high concentrations and ineffective at low concentrations. ANSYS Fluent has been used to study the drug distribution within the eye and in turn aid in the determination of the optimal drug (or implant) location within the eye. Buoyancy: Thermal gradients lead to flow circulation patterns in the eye, primarily in the aqueous humor. Drug Delivery to the Eye The following pictures show drug concentration evolution for two different implant locations. ANSYS Workbench based workflow has been developed which enables subsequent simulations with minimal manual effort. Partitioning between tissue layers and drug clearance from outer layers: This has been implemented using User Defined Functions (UDF) in ANSYS Fluent. After 10 days After 50 days After 100 days Sclera Choroid Retina Vitreous For accurate CFD modeling, following physics is included Porous zone modeling: Hydraulic resistance of the trabecular meshwork can be manipulated to produce the desired intraocular pressure. Outer Sclera: Episcleral venous pressure 10 torr Vitreous Lens Aqueous Humor CFD model of the Eye Cell Count ~ 1.1 M Computational Time = 20 Hrs on a single CPU Effect of drug implant location Fluid inflow on ciliary body behind iris Fluid outflow behind trabecular meshwork Iris Half symmetry model of the eye has been used. Outer Cornea: Atmospheric pressure 0 torr Please contact Marc Horner ([email protected]) for details

Drug Delivery to the Eye - Ansys · 2012-10-26 · Drug Delivery to the Eye The following pictures show drug concentration evolution for two different implant locations. ANSYS Workbench

  • Upload
    others

  • View
    3

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Drug Delivery to the Eye - Ansys · 2012-10-26 · Drug Delivery to the Eye The following pictures show drug concentration evolution for two different implant locations. ANSYS Workbench

Most of the drugs used to treat vitreo-retinal diseases have a narrow concentration range over which they are effective. They may be toxic at high concentrations and ineffective at low concentrations. ANSYS Fluent has been used to study the drug distribution within the eye and in turn aid in the determination of the optimal drug (or implant) location within the eye.

Buoyancy: Thermal gradients lead to flow circulation patterns in the eye, primarily in the aqueous humor.

Drug Delivery to the Eye

The following pictures show drug concentration evolution for two different implant locations. ANSYS Workbench based workflow has been developed which enables subsequent simulations with minimal manual effort.

Partitioning between tissue layers and drug clearance from outer layers: This has been implemented using User Defined Functions (UDF) in ANSYS Fluent.

After 10 days After 50 days After 100 days

Sclera Choroid Retina Vitreous

For accurate CFD modeling, following physics is included

Porous zone modeling: Hydraulic resistance of the trabecular meshwork can be manipulated to produce the desired intraocular pressure.

Outer Sclera: Episcleral venous pressure 10 torr

Vitreous Lens

Aqueous Humor

CFD model of the Eye

Cell Count ~ 1.1 M Computational Time = 20 Hrs on a single CPU

Effect of drug implant location

Fluid inflow on ciliary body behind iris

Fluid outflow behind trabecular meshwork

Iris

Half symmetry model of the eye has been used.

Outer Cornea: Atmospheric pressure 0 torr

Please contact Marc Horner ([email protected]) for details